EP3284520A1 — Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activity
Assigned to Shionogi and Co Ltd · Expires 2018-02-21 · 8y expired
What this patent protects
The present invention is to provide a novel compound shown below, having the anti-virus activity, particularly the HIV integrase inhibitory activity, and a drug containing the same, particularly an anti-HIV drug. wherein A ring is unsubstituted heterocycle; R 14 and R X …
USPTO Abstract
The present invention is to provide a novel compound shown below, having the anti-virus activity, particularly the HIV integrase inhibitory activity, and a drug containing the same, particularly an anti-HIV drug. wherein A ring is unsubstituted heterocycle; R 14 and R X are hydrogen; a broken line represents the absence of a bond; R 1 is hydrogen or C 1-10 alkyl; X is C 1-6 alkylene; R 2 is phenyl or phenyl substituted with at least halogen; and R 3 is hydrogen, halogen, hydroxy, C 1-10 alkyl, C 2-8 alkenyl, C 1-10 alkoxy, C 2-8 alkenyloxy or amino; or a pharmaceutically acceptable salt, or solvate thereof.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.